Abstract: In human pericardial resistance arteries, effects of the endothelium-dependent vasodilator bradykinin are mediated by NO during contraction induced by K + or the TxA 2 analogue U46619 and by H 2 O 2 during contraction by endothelin-1 (ET-1), respectively. We tested the hypotheses that ET-1 reduces relaxing effects of NO and increases those of H 2 O 2 in resistance artery smooth muscle of patients with cardiovascular disease. Arterial segments, dissected from the parietal pericardium of 39 cardiothoracic surgery patients, were studied by myography during amplitude-matched contractions induced by K + , the TXA 2 analogue U46619 or ET-1. Effects of the NO donor Na-nitroprusside (SNP) and of exogenous H 2 O 2 were recorded in the absence and presence of inhibitors of cyclooxygenases, NO synthases and small and intermediate conductance calcium-activated K + channels. During contractions induced by either of the three stimuli, the potency of SNP did not differ and was not modified by the inhibitors. In vessels contracted with ET-1, the potency of H 2 O 2 was on average and in terms of interindividual variability considerably larger than in K + -contracted vessels. Both differences were not statistically significant in the presence of inhibitors of mechanisms of endothelium-dependent vasodilatation. In resistance arteries from patients with cardiovascular disease, ET-1 does not selectively modify smooth muscle relaxing responses to NO or H 2 O 2 . Furthermore, the candidate endothelium-derived relaxing factor H 2 O 2 also acts as an endothelium-dependent vasodilator.
In large conduit arteries, NO is the main endothelium-derived relaxing factor (EDRF) [1, 2] . In small muscular resistancesized arteries, responses to endothelium-dependent vasodilators persist in the presence of inhibitors of NO synthesis [3] [4] [5] [6] [7] [8] [9] [10] [11] , can be inhibited by elevated extracellular [K + ] inhibitors of Ca 2+ -activated K + channels and of electrogenic sodium transport and are associated with hyperpolarization of the endothelial and smooth muscle cells [1, 2, 4, [6] [7] [8] [9] 12, 13] . In mouse and human mesenteric resistance arteries [4, 8] and in human adipose tissue arterioles [10] , coronary arterioles [9] and pericardial resistance arteries [11] , these responses are accompanied by an increased production of hydrogen peroxide (H 2 O 2 ) and can be inhibited by exogenously added catalase (scavenger of H 2 O 2 ). Additional bioassay evidence [12] strongly suggests that H 2 O 2 acts as an endothelium-derived hyperpolarizing factor (EDHF) in these arteries. Burgoyne et al. and Ohashi et al. [4, 14] demonstrated that both the endothelium and arterial smooth muscle cells (ASMC) contribute to augmented H 2 O 2 / EDHF-mediated relaxation in mouse mesenteric resistance arteries compared to aortae. The endothelium generates less NO, and the ASMC are more sensitive to the relaxing effect of H 2 O 2 in the resistance arteries than in the large conduit vessel.
Reductions in vasodilator, anti-inflammatory and antithrombotic properties of the endothelium are associated with most forms of cardiovascular disease (CVD) [2] . Oxidative stress reducing the bioavailability of endothelium-derived NO [15] contributes to this endothelial dysfunction in large conduit arteries. The complete picture may be more complex. In hyperlipidaemic and diabetic mice, EDHF-mediated resistance artery relaxations are reduced [16, 17] . In spontaneously hypertensive rats, arterial contractions mediated by endotheliumderived prostanoids are increased [18] . In experimental and human obesity, insulin resistance, type 2 diabetes and pulmonary hypertension, the endothelial endothelin (ET) system is unopposed or up-regulated in the microcirculation [19] [20] [21] . Still, Gutterman et al. and our group reported substantial relaxing responses to stimuli of endothelium-dependent relaxations (shear stress and bradykinin) during contraction induced by exogenous endothelin-1 (ET-1) in coronary, pericardial and adipose tissue resistance arteries from patients with ischaemic heart disease [9] [10] [11] [12] . We recently demonstrated that in pericardial resistance arteries from patients with CVD, relaxing responses to the endothelium-dependent vasodilator bradykinin are mediated by NO during contraction induced by high K + or thromboxane TP receptor agonist but by H 2 O 2 during contraction induced by ET-1 [11] . Here, we tested the hypotheses that in human pericardial resistance arteries, ET-1 increases H 2 O 2 -and reduces NOinduced arterial smooth muscle relaxation. To this end, we evaluated in resistance arteries harvested during cardiothoracic surgery, whether the relaxing effects of Na-nitroprusside are reduced and those of exogenously administered H 2 O 2 are increased in the presence of ET-1 compared to other vasoconstrictor stimuli. Our results may be relevant in obesity, insulin resistance, renal failure and pulmonary hypertension where the ET system is up-regulated in resistance arteries [19] [20] [21] .
Materials and Methods
Patients and ethics. From 39 patients with cardiovascular disease, biopsies of the parietal pericardium (approximately 2 9 2 cm) were collected in physiological salt solution (PSS) at the onset of elective cardiothoracic surgery (coronary artery bypass grafting and/or cardiac valve replacement) [11, 22] . Patient characteristics are summarized in table 1. All experiments were performed in accordance with institutional guidelines and were approved by the Medical Ethical Committee of the Region of Southern Denmark (S-20100044 and S-20140202). Experiments conformed to the principles outlined in the Declaration of Helsinki [23] , and informed written consent was obtained from all patients prior to collection of the biopsy and patient information. Contractile responses (N/m) of patient pericardial resistance arteries in the absence and presence of inhibitors of mechanisms of endothelium-dependent relaxations.
Indomethacin n = 14-15
Indomethacin L-NAME TRAM-34
Indomethacin L-NAME TRAM-34 Recording of vasomotor responses. The biopsies of the human pericardium were stored for 16 hr in 30 mL PSS at 4°C to wash away anaesthetics and analgesics administered during surgery [24] . Then, an artery was dissected from the tissue, cleaned from perivascular adipose tissue and divided into three to four segments each 2 mm long [11, 22] . The arterial preparations were mounted in wire myograph organ chambers (Danish Myo Technology A/S, Aarhus, DK) for recording of isometric wall tension [6, 7] . They were distended in PSS at 37°C until a lumen diameter and resting wall tension were obtained that according to the law of Laplace correspond to a transmural pressure of 100 mmHg [11] . The lumen diameter of 126 arterial segments under these conditions averaged 193 AE 9 lm (mean of means AE S.E.M., n = 39).
Pharmacological protocols. With at least 30-min. interval, arterial segments were stimulated to contract in series with K + , U46619 or ET-1. During these contractions, cumulative concentration-response curves (CCRCs) were constructed with SNP (1 nM-3 lM) or exogenous H 2 O 2 (0.1 lM-3 mM) increasing their concentration at 3-min. interval. Arterial segments from the same individual patient were studied in parallel in the absence and presence of 10 lM indomethacin (inhibitor of cyclooxygenases, COX) [25] , indomethacin and 100 lM L-NAME (inhibitor of NOS) [25] or indomethacin, L-NAME, 1 lM UCL 1684 and 1 lM TRAM-34 (inhibitors of small and intermediate conductance Ca 2+ -activated K + channels, K Ca 2.3 and K Ca 3.1, respectively) [26] . Additional parallel comparisons of the relaxing effects of exogenous H 2 O 2 were made in the absence and presence of L-NAME and of indomethacin, L-NAME, UCL 1684, TRAM-34 plus 10 lM ODQ (inhibitor of soluble guanylate cyclase, sGC). These protocols are comparable to those previously used in studies of EDH(F) [3, 4, [6] [7] [8] . The pharmacological inhibitors will be referred to as inhibitors of mechanisms of endothelium-dependent relaxation (EDR). We used this indirect approach because mechanical removal and selective chemical damage of the endothelium proved to be difficult and poorly reproducible in human pericardial resistance arteries. This contrasts with experimental animal resistance arteries that we investigated previously and may be related to the unusual structure of the internal elastic lamina in the pericardial resistance arteries [22] . For a few patients, arterial segments did not contract in response to all three contractile stimuli, but only to two of K + , ET-1 and U46619. Also in a few cases, the pericardial biopsy itself or its arterial tree was too small to obtain the desired four or more arterial segments for parallel studies. These explain that the number of experiments differs between different combinations of contractile stimuli and inhibitors of mechanisms of EDR.
Statistics. Results were expressed as contractile response (N/m) or as percentage reduction in the contraction (relaxations). Data are shown as mean AE S.E.M. or as median (interquartile range) when a large number of observations proved not to be normally distributed, with n denoting the number of individual patients. Individual CCRCs were fitted to a nonlinear regression curve with variable slope. For paired comparison of potency (pD 2 ; -log 10 IC 50 ) and efficacy (E max ) of SNP and H 2 O 2 during different conditions, two-sided t-test was used. Comparisons of pD 2 and E max of SNP and H 2 O 2 between control K + -, U46619-and ET-1-contracted arteries were made with one-way ANOVA, with Bonferroni's post hoc test to compare multiple groups. p < 0.05 was considered statistically significant. All analyses were performed using GraphPad Prism 6.04 (GraphPad Software Inc., San Diego, CA, USA).
Results

Contractile responses.
Isolated arterial segments were stimulated sequentially at 30-min. interval with K + , U46619 and ET-1 to induce amplitudematched contractions. The amplitudes of these contractions were 1.0 (0.6-1.9), 1.2 (0.7-2.2) and 1.4 (0.9-2.1) N/m for 32 mM K + , 1 lM U46619 and 2 nM ET-1, respectively (n = 39). Single and combined inhibitors of mechanisms of EDR did not cause contraction. In parallel comparisons between arterial segments of the same patients, the responses to each of the contractile stimuli were not significantly modified by 10 lM indomethacin, 100 lM L-NAME, 1 lM UCL 1684 and 1 lM TRAM-34 or 10 lM ODQ (table 2) .
Relaxing responses to SNP. In contracted pericardial resistance arteries, SNP (1 nM-3 lM) caused marked concentration-dependent relaxations ( fig. 1A ). The potency of SNP was similar during contractions induced by 32 mM K + , 1 lM U46619 or 2 nM ET-1; pD 2 :
7.1 AE 0.1, 7.2 AE 0.3 and 7.6 AE 0.2, respectively (n = 9) (figs 1A and 2). Between arteries from different patients, the sensitivity to the relaxing effect of SNP varied less than one Maximal relaxing responses to the NO donor were significantly smaller during U46619-induced contractions compared to the other contractile stimuli (E max : À100 AE 7%, À77 AE 8% and À98 AE 1% for K + , U46619 and ET-1, respectively) ( fig. 1 and table 3 ). Figure 1A confirms earlier findings in pericardial resistance arteries from a different group of patients [11] .
In the presence of each of the three contractile stimuli investigated, the potency and the efficacy of SNP were not significantly modified by indomethacin alone, indomethacin and L-NAME or the combination of indomethacin, L-NAME, UCL 1684 and TRAM-34 ( figs 1B and 2) . The significantly smaller efficacy of SNP during contraction stimulated by U46619 persisted in the presence of these inhibitors of COX, NOS, K Ca 2.3 and K Ca 3.1 ( fig. 1B and table 3 ).
During contraction induced by ET-1, 10 lM ODQ markedly reduced the potency and the observed maximal relaxing effect of SNP ( fig. 3 ). This indicates that also in pericardial resistance arteries from patients with CVD stimulated by exogenous ET-1, the NO donor SNP mainly causes relaxation via the stimulation of sGC. (fig. 4, table 3 ). In paired comparison of contractions induced by U46619 and ET-1, the relaxing efficacy of H 2 O 2 was significantly smaller during contraction induced by the TxA 2 analogue than during contraction stimulated by ET-1 ( fig. 4 and table 3 ).
In arteries contracted by 32 mM K + , the relaxing potency of H 2 O 2 was not significantly modified by indomethacin and/ or L-NAME, or ODQ but was significantly reduced by additional presence of the K Ca 2.3 and K Ca 3.1 channel inhibitors UCL 1684 and TRAM-34 ( fig. 5 ). In arterial segments contracted by U46619 or ET-1, the sensitivity to H 2 O 2 and the interindividual variability of the relaxing potency of this reactive oxygen species were reduced by inhibitors of mechanisms of EDR ( fig. 5 ). These effects were statistically significant during combined inhibition of COX, NOS, K Ca 2.3 and K Ca 3.1 and were most marked in the arteries from those individual patients that displayed the largest sensitivity to exogenously administered H 2 O 2 in the absence of inhibitors of EDR ( fig. 5 ). When several mechanisms of EDR were inhibited, that is in the presence of indomethacin, L-NAME, TRAM-34 and UCL 1684 with or without ODQ, the relaxing potency of Figure 4B confirms earlier findings in pericardial resistance arteries from a different group of patients [11] .
Discussion
In pericardial resistance arteries from patients with CVD, (i) the relaxing potency of SNP was comparable in the presence of different contractile stimuli and was not modified by pharmacological inhibitors of mechanisms of EDR, while (ii) the relaxing potency of exogenous H 2 O 2 was larger during agonist-stimulated compared to K + -induced contraction, reduced by inhibitors of mechanisms of EDR and varied extensively between arteries of different patients. We study resistance arteries from biopsies of the parietal pericardium because they can be frequently obtained during cardiothoracic surgery in patients with or without coronary artery disease treated with various standard cardiovascular and antithrombotic drugs [11, 22] . This provides us with opportunities to evaluate vascular pharmacological properties of patients with pre-existing or acquired resistance to drug therapy. In these vessels, we recently demonstrated that effects of the endothelium-dependent vasodilator bradykinin are mediated by NO or H 2 O 2 depending on whether the tissue is stimulated to contract with depolarizing buffer or the TP receptor agonist U46619 on the one hand and the endothelium-derived contractile peptide ET-1 on the other hand [11] . This can involve effects of the contractile stimuli on endothelial function and on the excitation-contraction coupling in the arterial smooth muscle. In this study, we evaluated the contribution of the latter. Selective removal of the endothelium by mechanical or chemical methods without damage to the smooth muscle proved to be difficult and poorly reproducible in these human pericardial resistance arteries. The unusual structure of the internal elastic lamina [22] and the small contractility of the smooth muscle in these vessels (maximal contractility: approximately 1.5 N/m versus 5.0 and 10.0 N/m in rat mesenteric and pig pericardial resistance arteries, respectively [11, 22] ) Table 3 . Maximal relaxing responses (%) to Na-nitroprusside (SNP) and H 2 O 2 in patient pericardial resistance arteries during contractile responses to different stimuli in the absence and presence of inhibitors of mechanisms of endothelium-dependent relaxations.
Indomethacin L-NAME TRAM-34 UCL 1684 ODQ Control n = 16
Indomethacin L-NAME n = 6-9
Indomethacin L-NAME TRAM-34 UCL 1684 n = 9-14
Indomethacin L-NAME TRAM-34 UCL 1684 ODQ n = 7-9 may have contributed. Instead, we used pharmacological inhibitors of several established mechanisms of EDR, such as COX, NOS, K Ca 2.3 and K Ca 3.1. Cytochrome P450 epoxygenases and myo-endothelial gap junctions can also contribute to EDR [1] but these were not inhibited in this investigation. In a previous study [11] , indomethacin, L-NAME with or without catalase already reduced the relaxing effects of bradykinin by more than 90%.
Human pericardial resistance artery contractile responses to exogenous ET-1 are mediated by ET A receptors and are neither promoted nor reduced by ET B receptor stimulation [11] . Our study focused on acute effects of ET-1. It did not address potential long-term effects of the peptide. For instance, longterm incubation with ET-1 induces down-regulation of ET A mRNA expression in the vascular smooth muscle of coronary arteries, but does not affect protein levels or ET A receptormediated vasoconstrictor responses [27] . In ASMC, contractile agonists stimulate not only electromechanical coupling (depolarization causing influx of Ca 2+ via voltage-operated calcium channels) but also GTP binding regulatory proteins, phospholipases and protein kinases. This pharmaco-mechanical coupling differs during ET A and TP receptor stimulation [28, 29] . ET-1 also stimulates NADPH oxidases to generate superoxide anions [30, 31] that can be converted into H 2 O 2 and impair NO-mediated signalling. They rapidly scavenge NO and inhibit its stimulatory effects on sGC [15, 32] . Hereby, ASMC levels of cGMP are reduced and activity of cGMP-dependent PKGIa is reduced, while levels of oxidized cGMP-independent dimers of PKGIa, which can be stimulated by H 2 O 2 and activate BK Ca , are increased [4, 14, 33, 34] . Despite these candidate mechanisms, (i) the relaxing potency of the NO donor compound SNP did not differ between arteries stimulated with K + , U46619 or ET-1 and (ii) the relaxing potency of exogenously administered H 2 O 2 did not differ between contractions stimulated by either of the three contractile stimuli in the presence of several inhibitors of EDR.
Potency and efficacy of the NO donor were not modified by inhibitors of COX, NOS, K Ca 2.3 and K Ca 3.1, in line with the widely accepted direct relaxing effect of NO on ASMC. In arteries contracted by ET-1, effects of SNP were markedly reduced by ODQ, indicating involvement of sGC generating cGMP also in human resistance arteries stimulated with ET-1. The NO/cGMP/PKG pathway was reported to (i) inhibit phospholipase C and Rho kinase, (ii) reduce the affinity of sarcoplasmic reticulum InsP3 receptors and of sarcolemmal TP receptors for their endogenous agonists and (iii) activate sarcoplasmic reticulum Ca 2+ ATPase and sarcolemmal BK Ca in ASMC [35] . Still, effects of SNP did not differ significantly between vessels stimulated with K + , U46619 or ET-1. ET-1 therefore does not seem to selectively impair the NO/cGMP/ PKG pathway in ASMC. It remains to be established whether inhibition of sGC would be more or less potent in reducing relaxing responses to SNP during ET-1-induced contraction compared to the other two contractile stimuli. Maximal relaxing responses to SNP and H 2 O 2 were smaller during U46619-than during ET-1-induced contractions. This might be because TxA 2 stimulates release of superoxide anions, up-regulates phosphodiesterases that hydrolyse cGMP, inhibits calcium-activated potassium channels and reduces endothelium-dependent hyperpolarization [36, 37] .
Unlike SNP, exogenous H 2 O 2 was more potent in relaxing arteries contracted with agonist (especially ET-1) than K + .
This and the previously observed inhibition of these relaxing responses by iberiotoxin (inhibitor of BK Ca ) [11] indicate the involvement of ASMC hyperpolarization. Although these channels can be activated by H 2 O 2 via a cGMP-independent action of PKG [36] , more indirect mechanisms seem to be involved. In ET-1-contracted vessels from patients exhibiting a high sensitivity to exogenous H 2 O 2 , pharmacological inhibitors of EDR significantly reduced the potency of the peroxide and inhibited the difference in potency between ET-1-and K + -contracted segments. That several candidate mechanisms of EDR needed to be inhibited might be due to redundancy of EDR mechanisms or to a specific involvement of K Ca 2.3/ K Ca 3.1 which we failed to address in the absence of COX and NOS inhibitors. In rabbit arteries, H 2 O 2 was reported to stimulate calcium release from the endoplasmic reticulum in endothelial cells, thereby activating endothelial K Ca 2.3/K Ca 3.1 channels [37] . Here, the combination of exogenous H 2 O 2 and ET-1, an endothelium-dependent and endothelium-independent vasodilator and a candidate endothelium-derived vasoconstrictor and endothelium-oxidative peptide provided a broad 4 log 10 wide window on individual vasodilator responses. It will be of interest to verify this in conditions where the endogenous endothelin system is up-regulated, such as pulmonary hypertension, renal failure, obesity and insulin resistance [19] [20] [21] 38, 39] . The origins of the marked interindividual variability illustrated in figs 3 and 5 are of interest in view of the now recognized need for individualized medicine of cardiovascular diseases. To unravel them will require studies with larger numbers of patient arteries and multivariate analyses. For instance, a patient with diabetes that requires cardiothoracic surgery will have been treated with an oral antidiabetic drug and can have had his hypertension and dyslipidaemia treated with an angiotensin-converting enzyme inhibitor and a statin, respectively.
The observed comparable relaxing potencies of exogenous H 2 O 2 in arteries contracted by K + , U46619 or ET-1 in the presence of inhibitors of mechanisms of EDR go against the second part of our hypothesis; namely, that ET-1 would promote the H 2 O 2 /PKG/BK Ca pathway in ASMC as observed with oxidative stress [14, 32, 34, 35] . In pericardial resistance arteries from patients with cardiovascular disease, exogenous ET-1 does not selectively impair ASMC relaxing responses to NO and does not promote ASMC relaxing responses to H 2 O 2 . The previously observed effect of the peptide on the mechanism of action of the endothelium-dependent dilator bradykinin shifting its mediator from NO to H 2 O 2 [11] is thus more likely due to effects of ET-1 on the bioavailability of endothelium-derived NO and H 2 O 2 . Furthermore, results with pharmacological inhibitors of EDR indicate that the candidate endothelium-derived relaxing factor H 2 O 2 also acts as an endothelium-dependent vasodilator in human resistance arteries. A, indomethacin + L-NAME + TRAM-34+ UCL 1684+ ODQ; B, ODQ; C, control; D, indomethacin; E, indomethacin + L-NAME; F, indomethacin + L-NAME + TRAM-34+ UCL 1684. *, the difference from control (C) is statistically significant.
